Rxo, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
RXO
Rxo, INCRXO schedules a virtual May 12, 2026 annual meeting to elect directors, ratify Deloitte, expand its 2022 equity plan by 7 million shares, and hold an advisory say‑on‑pay vote.
NYSE
RXO
Rxo, INCRXO, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NYSE
RXO
Rxo, INCRXO, Inc. has set the date for its 2025 Annual Meeting of Stockholders and announced that Brad Jacobs will not seek reelection, with Drew Wilkerson slated to become the new Chairman.
NYSE
RXO
Rxo, INCDEF 14A: RXO Inc. Seeks Stockholder Approval for Warrant Issuance to Fund Coyote Logistics Acquisition
RXO Inc. is holding a special meeting on December 5, 2024, to seek stockholder approval for the issuance of common stock upon the exercise of warrants, which were part of a private placement used to partially fund the acquisition of Coyote Logistics.
NYSE
RXO
Rxo, INCRXO, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to its upcoming shareholder meeting.
NYSE
RXO
Rxo, INCDEF 14A: RXO, Inc. Announces Details for 2024 Annual Stockholders Meeting and Executive Compensation
RXO, Inc. has released its proxy statement detailing the agenda for its 2024 Annual Meeting of Stockholders, including the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.